HIV screening in pregnant women: A systematic review of cost-effectiveness studies.

Fabrizio BertMaria Rosaria GualanoPaolo BianconeValerio BresciaElisa CamussiMaria MartoranaRobin ThomasSilvana SecinaroRoberta Siliquini

Published in: The International journal of health planning and management (2017)

The review confirmed the cost-effectiveness not only of HIV universal antenatal screening but also of rescreening in late gestation in both developed and developing countries. Universal screening is cost-effective even in case of extremely low HIV prevalence. Therefore, to maximize screening, coverage appears as a worldwide priority. In certain settings, a targeted screening towards high-risk groups could be a valuable option.

Keyphrases

pregnant women
antiretroviral therapy
hiv positive
hiv infected
human immunodeficiency virus
hepatitis c virus
hiv aids
risk factors
preterm birth